Latest filing published 24 Mar 2026 for Vir Biotechnology, Inc., €61k.
Brent Sabatini appears in our data through filings on Vir Biotechnology, Inc. shares, published by SEC (Form 4). In total, 8 filings cover trades dated from 13 February 2025 to 23 March 2026.
Every open-market trade on record is a sale: 6 sales worth €122k. The rest of the record consists of 2 share grants. Since January 2026: no purchases and 4 sales on the market.
The latest filing, published on 24 March 2026, reports an open-market sale of €61k in Vir Biotechnology, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations